Inhibition of STAT3 has been reported to reduce eosinophilic infiltration, cytokine release, and airway hyperresponsiveness in asthma models, while also attenuating IL-6-mediated inflammatory signaling and airway remodeling in COPD [34,35,36]. This evidence concerns the gene STAT3 and chronic obstructive pulmonary disease.